TENAX THERAPEUTICS, INC. Preferred Stock, Shares Issued
TENAX THERAPEUTICS, INC. (TENX) had Preferred Stock, Shares Issued of 10.00 million shares as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2026-07-31
- 2026-06-30: Preferred Stock, Shares Issued 10.00M shares.
- 2026-03-31: Preferred Stock, Shares Issued 10.00M shares.
- 2025-12-31: Preferred Stock, Shares Issued 10.00M shares.
- 2025-09-30: Preferred Stock, Shares Issued 10.00M shares.
| Period end | Preferred Stock, Shares Issued | Preferred Stock, Shares Issued as first filed |
|---|---|---|
| 2026-06-30 | 10.00M shares 10-Q · filed 2026-07-31 | |
| 2026-03-31 | 10.00M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 10.00M shares 10-K · filed 2026-03-10 | |
| 2025-09-30 | 10.00M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 10.00M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 10.00M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 10.00M shares 10-K · filed 2025-03-25 | |
| 2024-09-30 | 10.00M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 10.00M shares 10-Q · filed 2024-08-13 | |
| 2023-12-31 | 10.00M shares 10-Q · filed 2024-11-13 | |
| 2023-03-31 | 5.18M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 210.00 shares 10-Q · filed 2023-05-15 | |
| 2013-04-30 | 2.10K shares 10-K · filed 2013-06-26 | |
| 2013-01-31 | 0.00 shares 10-Q · filed 2013-03-18 | |
| 2012-10-31 | 0.00 shares 10-Q · filed 2012-12-14 | |
| 2012-07-31 | 0.00 shares 10-Q · filed 2012-09-19 | |
| 2012-04-30 | 2.10K shares 10-K · filed 2013-06-26 | 0.00 shares 10-K · filed 2012-07-25 |
| 2012-01-31 | 0.00 shares 10-Q · filed 2012-03-15 | |
| 2011-10-31 | 0.00 shares 10-Q · filed 2011-12-15 | |
| 2011-07-31 | 0.00 shares 10-Q · filed 2011-09-19 | |
| 2011-04-30 | 0.00 shares 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |